Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1

Archive ouverte

Wenninger, Stephan | Cumming, Sarah | Gutschmidt, Kristina | Okkersen, Kees | Jimenez-Moreno, Aura Cecilia | Daidj, Ferroudja | Lochmüller, Hanns | Hogarth, Fiona | Knoop, Hans | Bassez, Guillaume | Monckton, Darren | van Engelen, Baziel G.M. | Schoser, Benedikt

Edité par CCSD ; American Academy of Neurology -

International audience. Objective To assess the association between variant repeat (VR) interruptions in patients with myotonic dystrophy type 1 (DM1) and clinical symptoms and outcome measures after cognitive behavioral therapy (CBT) intervention. Methods Adult patients with DM1 were recruited within the OPTIMISTIC trial ( NCT02118779 ). Disease-related history, current clinical symptoms and comorbidities, functional assessments, and disease- and health-related questionnaires were obtained at baseline and after 5 and 10 months. After genetic analysis, we assessed the association between the presence of VR interruptions and clinical symptoms' long-term outcomes and compared the effects of CBT in patients with and without VR interruptions. Core trial outcome measures analyzed were: 6-minute walking test, DM1-Activ-C, Checklist Individual Strength Fatigue Score, Myotonic Dystrophy Health Index, McGill-Pain questionnaire, and Beck Depression inventory—fast screen. Blood samples for DNA testing were obtained at the baseline visit for determining CTG length and detection of VR interruptions. Results VR interruptions were detectable in 21/250 patients (8.4%)—12 were assigned to the standard-of-care group (control group) and 9 to the CBT group. Patients with VR interruptions were significantly older when the first medical problem occurred and had a significantly shorter disease duration at baseline. We found a tendency toward a milder disease severity in patients with VR interruptions, especially in ventilation status, mobility, and cardiac symptoms. Changes in clinical outcome measures after CBT were not associated with the presence of VR interruptions. Conclusions The presence of VR interruptions is associated with a later onset of the disease and a milder phenotype. However, based on the OPTIMISTIC trial data, the presence of VR interruptions was not associated with significant changes on outcome measures after CBT intervention. Trial Registration Information ClinicalTrials.gov NCT02118779 .

Consulter en ligne

Suggestions

Du même auteur

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Archive ouverte | Okkersen, Kees | CCSD

International audience

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort

Archive ouverte | Cumming, Sarah | CCSD

International audience. Objective To evaluate the role of genetic variation at the DMPK locus on symptomatic diversity in 250 adult, ambulant patients with myotonic dystrophy type 1 (DM1) recruited to the Observatio...

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Archive ouverte | Flower, Michael | CCSD

International audience. Abstract The mismatch repair gene MSH3 has been implicated as a genetic modifier of the CAG·CTG repeat expansion disorders Huntington’s disease and myotonic dystrophy type 1. A recent Hunting...

Chargement des enrichissements...